People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other, Other Energy, Other Health Care, Healthtech, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LJ/HAH Holdings Corp | — | Other | Series D+ | $117.7M | $2.0B | 2010 |
| LJ Energy Services Holdings, LLC | — | Other Energy | Series D+ | $101.4M | $1.2B | 2014 |
| Abs Topco, Llc | — | Other Health Care | Series B | $25.5M | $34.2M | 2019 |
| forTRA Health, Inc. | — | Healthtech | Series B | $24.6M | $542.3M | 2019 |
| HealthLoop, Inc. | — | Healthtech | Series A | $23.8M | $189.7M | 2013 |
| Widevine Technologies Inc | — | Other Technology | Series A | $19.2M | $323.6M | 2009 |
| Prosperity Health Holdings LLC | — | Healthtech | Series B | $18.8M | $1.9M | 2022 |
| Prosperity Health Partners LLC | — | Healthtech | Series A | $15.6M | $3.3M | 2024 |
| Niveus Medical, Inc. | — | Healthtech | Seed | $4.7M | $14.6M | 2011 |
| ZRZ Holdings, LLC | — | Other | Seed | $1.8M | $33.9M | 2014 |
| Be-Thin, Inc. | — | Other | Pre-Seed | $525K | $12.1M | 2010 |
Michael Kaplan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Kaplan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Todd Johnson | 1 | 27 |
| Rebecca Lynn | 1 | 12 |
| Duncan Davidson | 1 | 12 |
| Michael Klein | 1 | 9 |
| Richard Lee | 1 | 7 |
| David Fitzgerald | 1 | 7 |
| Melissa Daniels | 1 | 6 |
| Andrew Klein | 1 | 6 |
| Ted Meisel | 1 | 5 |
| James J. Bochnowski | 1 | 5 |
| Mark Brooks | 1 | 5 |
| Brian Baker | 1 | 5 |
| Robert Brownell | 1 | 4 |
| Erik Engelson | 1 | 4 |
| Darren Dworkin | 1 | 3 |
| Jeffrey Rice | 1 | 3 |
| Scott Howe | 1 | 3 |
| Jason Whitt | 1 | 3 |
| Matthew Weil | 1 | 3 |
| Erik T. Engelson | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.